Src family kinases involved in CXCL12-induced loss of acute morphine analgesia

Brain, Behavior, and Immunity

Volumn 38, Issue , 2014, Pages 38-52

  Rivat, Cyril ^a   Sebaihi, Soumia ^b   Van Steenwinckel, Juliette ^c   Fouquet, Stéphane ^e   Kitabgi, Patrick ^b   Pohl, Michel ^d   Melik Parsadaniantz, Stéphane ^e   Reaux Le Goazigo, Annabelle ^e  

^a Montpellier University Medical Center   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM   (France)

^d CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

^e INSTITUT DE LA VISION   (France)

Author keywords

Analgesia; Chemokine; CXCR4; Microglia; Opioid receptors; Spinal cord; Src kinases

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; DELTA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; PROTEIN TYROSINE KINASE; STROMAL CELL DERIVED FACTOR 1; CXCL12 PROTEIN, RAT; CXCR4 PROTEIN, RAT; NARCOTIC ANALGESIC AGENT; 1,3 DICYCLOHEXYL 2 (3 METHYL 6,6 DIMETHYL 5,6 DIHYDROIMIDAZO[1,2 B]THIAZOLE) 2 THIOPSEUDOUREA; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUMBAR SPINAL CORD; MALE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SPINAL GANGLION; SPINAL NERVE; WESTERN BLOTTING; ANIMAL; DRUG EFFECTS; DRUG TOLERANCE; ENZYMOLOGY; METABOLISM; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; ADULT; ANIMAL CELL; CELL POPULATION; DRUG POTENCY; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IMMUNOREACTIVITY; NERVE ENDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SPINAL CORD;

ANALGESICS, OPIOID; ANIMALS; CHEMOKINE CXCL12; DRUG TOLERANCE; GANGLIA, SPINAL; MALE; MICROGLIA; MORPHINE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CXCR4; SRC-FAMILY KINASES;

EID: 84898548000     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.11.010     Document Type: Article

References (72)

1. Abbadie C., Pasternak G.W., Aicher S.A. Presynaptic localization of the carboxy-terminus epitopes of the mu opioid receptor splice variants MOR-1C and MOR-1D in the superficial laminae of the rat spinal cord. Neuroscience 2001, 106:833-842.
2. Archer-Lahlou E., Audet N., Amraei M.G., Huard K., Paquin-Gobeil M., Pineyro G. Src promotes delta opioid receptor (DOR) desensitization by interfering with receptor recycling. J. Cell Mol. Med. 2009, 13:147-163.
3. Belkouch M., Dansereau M.A., Reaux-Le Goazigo A., Van Steenwinckel J., Beaudet N., Chraibi A., Melik-Parsadaniantz S., Sarret P. The chemokine CCL2 increases Nav1.8 sodium channel activity in primary sensory neurons through a Gbetagamma-dependent mechanism. J. Neurosci. 2011, 31:18381-18390.
4. Bhangoo S., Ren D., Miller R.J., Henry K.J., Lineswala J., Hamdouchi C., Li B., Monahan P.E., Chan D.M., Ripsch M.S., White F.A. Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors. Mol. Pain. 2007, 3:38.
5. Billadeau D.D., Chatterjee S., Bramati P., Sreekumar R., Shah V., Hedin K., Urrutia R. Characterization of the CXCR4 signaling in pancreatic cancer cells. Int. J. Gastrointest. Cancer 2006, 37:110-119.
6. Cabioglu N., Summy J., Miller C., Parikh N.U., Sahin A.A., Tuzlali S., Pumiglia K., Gallick G.E., Price J.E. CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Res. 2005, 65:6493-6497.
7. Cahill C.M., McClellan K.A., Morinville A., Hoffert C., Hubatsch D., O'Donnell D., Beaudet A. Immunohistochemical distribution of delta opioid receptors in the rat central nervous system: evidence for somatodendritic labeling and antigen-specific cellular compartmentalization. J. Comp. Neurol. 2001, 440:65-84.
8. Celerier E., Laulin J., Larcher A., Le Moal M., Simonnet G. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats. Brain Res. 1999, 847:18-25.
9. Chen X., Geller E.B., Rogers T.J., Adler M.W. Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats. Drug Alcohol Depend. 2007, 88:36-41.
10. Clayton C.C., Bruchas M.R., Lee M.L., Chavkin C. Phosphorylation of the mu-opioid receptor at tyrosine 166 (Tyr3.51) in the DRY motif reduces agonist efficacy. Mol. Pharmacol. 2010, 77:339-347.
11. Cui Y., Liao X.X., Liu W., Guo R.X., Wu Z.Z., Zhao C.M., Chen P.X., Feng J.Q. A novel role of minocycline: attenuating morphine antinociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia. Brain Behav. Immun. 2008, 22:114-123.
12. Ding Y.Q., Kaneko T., Nomura S., Mizuno N. Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat. J. Comp. Neurol. 1996, 367:375-402.
13. Dubovy P., Klusakova I., Svizenska I., Brazda V. Spatio-temporal changes of SDF1 and its CXCR4 receptor in the dorsal root ganglia following unilateral sciatic nerve injury as a model of neuropathic pain. Histochem. Cell Biol. 2010, 133:323-337.
14. Eisinger D.A., Ammer H. Down-regulation of c-Cbl by morphine accounts for persistent ERK1/2 signaling in delta-opioid receptor-expressing HEK293 cells. J. Biol. Chem. 2009, 284:34819-34828.
15. Finley M.J., Chen X., Bardi G., Davey P., Geller E.B., Zhang L., Adler M.W., Rogers T.J. Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptor. J. Neuroimmunol. 2008, 197:114-123.
16. Gavi S., Shumay E., Wang H.Y., Malbon C.C. G-protein-coupled receptors and tyrosine kinases: crossroads in cell signaling and regulation. Trends Endocrinol. Metab. 2006, 17:48-54.
17. Gosselin R.D., Dansereau M.A., Pohl M., Kitabgi P., Beaudet N., Sarret P., Melik Parsadaniantz S. Chemokine network in the nervous system: a new target for pain relief. Curr. Med. Chem. 2008, 15:2866-2875.
18. Guilbaud G., Peschanski M., Briand A., Gautron M. The organization of spinal pathways to ventrobasal thalamus in an experimental model of pain (the arthritic rat). Electrophysiol. Study. Pain. 1986, 26:301-312.
19. Hanke J.H., Gardner J.P., Dow R.L., Changelian P.S., Brissette W.H., Weringer E.J., Pollok B.A., Connelly P.A. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 1996, 271:695-701.
20. Hattermann K., Li G., Hugo H.H., Mentlein R., Mehdorn H.M., Held-Feindt J. Expression of the chemokines CXCL12 and CX3CL1 and their receptors in human nerve sheath tumors. Histol. Histopathol. 2013, 28:1337-1349.
21. Heinisch S., Palma J., Kirby L.G. Interactions between chemokine and mu-opioid receptors: anatomical findings and electrophysiological studies in the rat periaqueductal grey. Brain Behav. Immun. 2011, 25:360-372.
22. Hong M.H., Xu C., Wang Y.J., Ji J.L., Tao Y.M., Xu X.J., Chen J., Xie X., Chi Z.Q., Liu J.G. Role of Src in ligand-specific regulation of delta-opioid receptor desensitization and internalization. J. Neurochem. 2009, 108:102-114.
23. Horvath R.J., Romero-Sandoval E.A., De Leo J.A. Inhibition of microglial P2X4 receptors attenuates morphine tolerance, Iba1, GFAP and mu opioid receptor protein expression while enhancing perivascular microglial ED2. Pain 2010, 150:401-413.
24. Hutchinson M.R., Shavit Y., Grace P.M., Rice K.C., Maier S.F., Watkins L.R. Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacol. Rev. 2011, 63:772-810.
25. Kam A.Y., Chan A.S., Wong Y.H. Kappa-opioid receptor signals through Src and focal adhesion kinase to stimulate c-Jun N-terminal kinases in transfected COS-7 cells and human monocytic THP-1 cells. J. Pharmacol. Exp. Ther. 2004, 310:301-310.
26. Katsura H., Obata K., Mizushima T., Sakurai J., Kobayashi K., Yamanaka H., Dai Y., Fukuoka T., Sakagami M., Noguchi K. Activation of Src-family kinases in spinal microglia contributes to mechanical hypersensitivity after nerve injury. J. Neurosci. 2006, 26:8680-8690.
27. Kissin I., Brown P.T., Robinson C.A., Bradley E.L. Acute tolerance in morphine analgesia: continuous infusion and single injection in rats. Anesthesiology 1991, 74:166-171.
28. Knerlich-Lukoschus F., von der Ropp-Brenner B., Lucius R., Mehdorn H.M., Held-Feindt J. Spatiotemporal CCR1, CCL3(MIP-1alpha), CXCR4, CXCL12(SDF-1alpha), expression patterns in a rat spinal cord injury model of posttraumatic neuropathic pain. J. Neurosurg. Spine 2011, 14:583-597.
29. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science 1988, 242:715-723.
30. Kramer H.K., Andria M.L., Esposito D.H., Simon E.J. Tyrosine phosphorylation of the delta-opioid receptor. Evidence for its role in mitogen-activated protein kinase activation and receptor internalization. Biochem. Pharmacol. 2000, 60:781-792.
31. Larcher A., Laulin J.P., Celerier E., Le Moal M., Simonnet G. Acute tolerance associated with a single opiate administration: involvement of N-methyl-d-aspartate-dependent pain facilitatory systems. Neuroscience 1998, 84:583-589.
32. Laulin J.P., Maurette P., Corcuff J.B., Rivat C., Chauvin M., Simonnet G. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth. Analg. 2002, 94:1263-1269. Table of contents.
33. Lipfert J., Odemis V., Wagner D.C., Boltze J., Engele J. CXCR4 and CXCR7 form a functional receptor unit for SDF-1/CXCL12 in primary rodent microglia. Neuropathol. Appl. Neurobiol. 2013, 39:667-680.
34. Liu X.J., Gingrich J.R., Vargas-Caballero M., Dong Y.N., Sengar A., Beggs S., Wang S.H., Ding H.K., Frankland P.W., Salter M.W. Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complex. Nat. Med. 2008, 14:1325-1332.
35. Liu Q., Wang X., Liu Y., Lu R., Yuan Q., Yang B., Zhou J., Wang Y., Wang Z. RACK1 inhibits morphine re-exposure via inhibition of Src. Neurol. Res. 2011, 33:56-62.
36. Luo Y., Lathia J., Mughal M., Mattson M.P. SDF1alpha/CXCR4 signaling, via ERKs and the transcription factor Egr1, induces expression of a 67-kDa form of glutamic acid decarboxylase in embryonic hippocampal neurons. J. Biol. Chem. 2008, 283:24789-24800.
37. Luttrell D.K., Luttrell L.M. Not so strange bedfellows: G-protein-coupled receptors and Src family kinases. Oncogene 2004, 23:7969-7978.
38. Ossipov M.H., Lai J., Vanderah T.W., Porreca F. Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance. Life Sci. 2003, 73:783-800.
39. Patel J.P., Sengupta R., Bardi G., Khan M.Z., Mullen-Przeworski A., Meucci O. Modulation of neuronal CXCR4 by the micro-opioid agonist DAMGO. J. Neurovirol. 2006, 12:492-500.
40. Pello O.M., Martinez-Munoz L., Parrillas V., Serrano A., Rodriguez-Frade J.M., Toro M.J., Lucas P., Monterrubio M., Martinez A.C., Mellado M. Ligand stabilization of CXCR4/delta-opioid receptor heterodimers reveals a mechanism for immune response regulation. Eur. J. Immunol. 2008, 38:537-549.
41. Proudfoot A.E. Chemokine receptors: multifaceted therapeutic targets. Nat. Rev. Immunol. 2002, 2:106-115.
42. Reaux-Le Goazigo A., Bodineau L., De Mota N., Jeandel L., Chartrel N., Knauf C., Raad C., Valet P., Llorens-Cortes C. Apelin and the proopiomelanocortin system: a new regulatory pathway of hypothalamic alpha-MSH release. Am. J. Physiol. Endocrinol. Metab. 2011, 301:E955-966.
43. Reaux-Le Goazigo A., Rivat C.P., Kitabgi M., Pohl S. Melik Parsadaniantz, cellular and subcellular localization of CXCL12 and CXCR4 in rat nociceptive structures physiological relevance. Eur. J. Neurosci. 2012, 36:2619-2631.
44. Reaux-Le Goazigo A., Van Steenwinckel J., Rostene W., Melik Parsadaniantz S. Current status of chemokines in the adult CNS. Prog. Neurobiol. 2013, 104:67-92.
45. Rehni A.K., Singh N. Modulation of src-kinase attenuates naloxone-precipitated opioid withdrawal syndrome in mice. Behav. Pharmacol. 2011, 22:182-190.
46. Richebe P., Cahana A., Rivat C. Tolerance and opioid-induced hyperalgesia. Is a divorce imminent?. Pain 2012, 153:1547-1548.
47. Roskoski R. Src kinase regulation by phosphorylation and dephosphorylation. Biochem. Biophys. Res. Commun. 2005, 331:1-14.
48. Rostene W., Buckingham J.C. Chemokines as modulators of neuroendocrine functions. J. Mol. Endocrinol. 2007, 38:351-353.
49. Rostene W., Dansereau M.A., Godefroy D., Van Steenwinckel J., Reaux-Le Goazigo A., Melik-Parsadaniantz S., Apartis E., Hunot S., Beaudet N., Sarret P. Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system. J. Neurochem. 2011, 118:680-694.
50. Sengupta R., Burbassi S., Shimizu S., Cappello S., Vallee R.B., Rubin J.B., Meucci O. Morphine increases brain levels of ferritin heavy chain leading to inhibition of CXCR4-mediated survival signaling in neurons. J. Neurosci. 2009, 29:2534-2544.
51. Szabo I., Rogers T.J. Crosstalk between chemokine and opioid receptors results in downmodulation of cell migration. Crosstalk Between Chemokine and Opioid Receptors Results in Downmodulation of Cell Migration 2001, 75-79. Plenum Press, New York. H.K.T. Friedman, J. Madden (Eds.).
52. Szabo I., Chen X.H., Xin L., Adler M.W., Howard O.M., Oppenheim J.J., Rogers T.J. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc. Natl. Acad. Sci. USA 2002, 99:10276-10281.
53. Tan Y.H., Li K., Chen X.Y., Cao Y., Light A.R., Fu K.Y. Activation of Src family kinases in spinal microglia contributes to formalin-induced persistent pain state through p38 pathway. J. Pain 2012, 13:1008-1015.
54. Thomas S.M., Brugge J.S. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 1997, 13:513-609.
55. Tseng T.J., Chen C.C., Hsieh Y.L., Hsieh S.T. Influences of surgical decompression on the dorsal horn after chronic constriction injury: changes in peptidergic and delta-opioid receptor (+) nerve terminals. Neuroscience 2008, 156:758-768.
56. Tysseling V.M., Mithal D., Sahni V., Birch D., Jung H., Miller R.J., Kessler J.A. SDF1 in the dorsal corticospinal tract promotes CXCR4+ cell migration after spinal cord injury. J. Neuroinflammation 2011, 8:16.
57. Uchida D., Begum N.M., Almofti A., Nakashiro K., Kawamata H., Tateishi Y., Hamakawa H., Yoshida H., Sato M. Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp. Cell Res. 2003, 290:289-302.
58. Van Steenwinckel J., Reaux-Le Goazigo A., Pommier B., Mauborgne A., Dansereau M.A., Kitabgi P., Sarret P., Pohl M., Melik Parsadaniantz S. CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury. J. Neurosci. 2011, 31:5865-5875.
59. Vanderah T.W., Gardell L.R., Burgess S.E., Ibrahim M., Dogrul A., Zhong C.M., Zhang E.T., Malan T.P., Ossipov M.H., Lai J., Porreca F. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J. Neurosci. 2000, 20:7074-7079.
60. Vanderah T.W., Suenaga N.M., Ossipov M.H., Malan T.P., Lai J., Porreca F. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J. Neurosci. 2001, 21:279-286.
61. Walwyn W., Evans C.J., Hales T.G. Beta-arrestin2 and c-Src regulate the constitutive activity and recycling of mu opioid receptors in dorsal root ganglion neurons. J. Neurosci. 2007, 27:5092-5104.
62. Wang Z., Ma W., Chabot J.G., Quirion R. Cell-type specific activation of p38 and ERK mediates calcitonin gene-related peptide involvement in tolerance to morphine-induced analgesia. FASEB J. 2009, 23:2576-2586.
63. Wang Z., Ma W., Chabot J.G., Quirion R. Morphological evidence for the involvement of microglial p38 activation in CGRP-associated development of morphine antinociceptive tolerance. Peptides 2010, 31:2179-2184.
64. Watkins L.R., Hutchinson M.R., Johnston I.N., Maier S.F. Glia: novel counter-regulators of opioid analgesia. Trends Neurosci. 2005, 28:661-669.
65. White F.A., Bhangoo S.K., Miller R.J. Chemokines: integrators of pain and inflammation. Nat. Rev. Drug Discov. 2005, 4:834-844.
66. Williams J.T., Ingram S.L., Henderson G., Chavkin C., von Zastrow M., Schulz S., Koch T., Evans C.J., Christie M.J. Regulation of mu-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol. Rev. 2013, 65:223-254.
67. Wilson N.M., Jung H., Ripsch M.S., Miller R.J., White F.A. CXCR4 signaling mediates morphine-induced tactile hyperalgesia. Brain Behav. Immun. 2011, 25:565-573.
68. Wu B., Chien E.Y., Mol C.D., Fenalti G., Liu W., Katritch V., Abagyan R., Brooun A., Wells P., Bi F.C., Hamel D.J., Kuhn P., Handel T.M., Cherezov V., Stevens R.C. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010, 330:1066-1071.
69. Yoshikawa Y., Oishi S., Kubo T., Tanahara N., Fujii N., Furuya T. Optimized method of G-protein-coupled receptor homology modeling: its application to the discovery of novel CXCR7 ligands. J. Med. Chem. 2013, 56:4236-4251.
70. Zhang L., Zhao H., Qiu Y., Loh H.H., Law P.Y. Src phosphorylation of micro-receptor is responsible for the receptor switching from an inhibitory to a stimulatory signal. J. Biol. Chem. 2009, 284:1990-2000.
71. Zhao P., Waxman S.G., Hains B.C. Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21. J. Neurosci. 2007, 27:8893-8902.
72. Zhou H.Y., Chen S.R., Chen H., Pan H.L. Opioid-induced long-term potentiation in the spinal cord is a presynaptic event. J. Neurosci. 2010, 30:4460-4466.